PHOTOCURE ASA OSLO , Norway, April 5, 2024 - Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces that President and Chief Executive Officer, Dan Schneider will present a corporate overview and host 1-on-1 meetings with investors at the 23[rd] AnnualNeedham Healthcare Conference being held virtually April 8-11, 2024. Presentation Details: Date:April 11, 2024 Time: 10:15am ET (4:15pm CET ) Webcast Link: https://wsw.com/webcast/needham117/pho.ol/2531984 About theNeedham Healthcare Conference The 23[rd] AnnualNeedham Virtual Healthcare Conference will feature leading public and private companies in the Biotechnology,Specialty Pharmaceuticals , Medical Technology, and Diagnostics sectors. AboutPhotocure ASA Photocure :The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide.Photocure is headquartered in Oslo, Norway and listed on theOslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com For further information, please contact:Dan Schneider President and CEOPhotocure ASA Email: ds@photocure.comErik Dahl CFOPhotocure ASA Tel: +4745055000 Email: ed@photocure.comDavid Moskowitz Vice President, Investor RelationsPhotocure ASA Tel: +1 202 280 0888 Email: david.moskowitz@photocure.com Media and IR enquiries: Geir Bjørlo Corporate Communications (Norway ) Tel: +47 91540000 Email: geir.bjorlo@corpcom.no
Click here for more information
© Oslo Bors ASA, source
